ExodusPoint Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-250,414
| Closed | -$5.48M | – | 1372 |
|
|
2025
Q1 | $5.48M | Buy |
+250,414
| New | +$5.48M | 0.05% | 357 |
|
|
2024
Q3 | – | Sell |
-73,133
| Closed | -$2.81M | – | 1472 |
|
|
2024
Q2 | $2.81M | Buy |
73,133
+33,013
| +82% | +$1.27M | 0.02% | 553 |
|
|
2024
Q1 | $2.36M | Buy |
+40,120
| New | +$2.36M | 0.02% | 539 |
|
|
2023
Q3 | – | Sell |
-33,187
| Closed | -$3.02M | – | 1620 |
|
|
2023
Q2 | $3.02M | Buy |
33,187
+10,119
| +44% | +$922K | 0.02% | 569 |
|
|
2023
Q1 | $1.52M | Buy |
23,068
+8,276
| +56% | +$546K | 0.01% | 904 |
|
|
2022
Q4 | $765K | Buy |
+14,792
| New | +$765K | 0.01% | 1011 |
|
|
2022
Q1 | – | Sell |
-13,939
| Closed | -$659K | – | 2104 |
|
|
2021
Q4 | $659K | Buy |
+13,939
| New | +$659K | 0.01% | 1228 |
|
|
2021
Q3 | – | Sell |
-10,000
| Closed | -$632K | – | 2020 |
|
|
2021
Q2 | $632K | Buy |
+10,000
| New | +$632K | 0.01% | 1167 |
|
|
2020
Q4 | – | Sell |
-15,456
| Closed | -$466K | – | 1860 |
|
|
2020
Q3 | $466K | Buy |
+15,456
| New | +$466K | 0.01% | 1001 |
|